Ooops. My bad. Wrong direction for eGFR. -0.4 apabetalone vs. +2.1 placebo. Though statistically significant, this is not clinically significant since baseline eGFR for total population was like 90 or 99.
We'll have to wait for the CKD sub-study results to see if apabetalone elicited an eGFR improvement in those w/ baseline eGFR <60.
BDAZ